Related Experiment Video
Updated: Feb 9, 2026

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
Published on: May 12, 2023
Immunity War: A Novel Therapy for Lymphoma Using T-cell Bispecific Antibodies
Ajay Prakash1, Catherine S Diefenbach2
1Department of Hematology-Oncology, NYU Perlmutter Cancer Center, NYU Langone Health, New York, New York.
Abstract:
The activity of T-cell-mediated immunotherapies in B-cell lymphoma has been limited to date. The novel bispecific antibody CD20-TCB has a 2:1 antibody design to maximize T-cell engagement and demonstrates activity in preclinical models. This may represent a novel therapeutic approach for patients with relapsed/refractory non-Hodgkin lymphoma (NHL). Clin Cancer Res; 24(19); 4631-2. ©2018 AACR See related article by Bacac et al., p. 4785.
Related Concept Videos
What is the Immune System?
Humoral Immune Responses
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Gene Therapy
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response

